EZH2 and breast carcinoma: We found that in breast cancer patients, EZH2 expression scores correlated significantly with Ki-67 expression scores in both primary and metastatic lesions and Ki-67 expression and EZH2 expression scores were significantly higher in metastatic lesions compared with PBC lesions.